Metabolic basis of hypotriglyceridemic effects of insulin in normal men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 7, 1997, Pages 1454-1464

  Malmström, Raija ^a   Packard, Christopher J ^b   Watson, Timothy D G ^b   Rannikko, Sirpa ^a   Caslake, Muriel ^b   Bedford, Dorothy ^b   Stewart, Philip ^b   Yki Järvinen, Hannele ^a   Shepherd, James ^b   Taskinen, Marja Riitta ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Apolipoprotein B; Euglycemic clamping; Kinetics; Stable isotopes; VLDL

Indexed keywords

APOLIPOPROTEIN B; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID METABOLISM; MALE; METABOLIC REGULATION; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 16944367066     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.7.1454     Document Type: Article

References (17)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88:381-387.
3. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
4. Fontbonne A, Eschwege E, Cambien F, Richard J, Ducimetiere P, Thibult N, Warnet JM, Claude JR, Rosselin GE. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia. 1989;32:300-304.
5. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation. 1992;85:37-45.
6. Griffin BA, Packard CJ. Metabolism of VLDL and LDL subclasses. Curr Opin Lipidol. 1994;5:200-206.
7. Fisher RM, Coppack SW, Gibbons GF, Frayn KN. Post-prandial VLDL subfraction metabolism in normal and obese subjects. Int J Obes. 1993;17:263-269.
8. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
9. Gaw A, Packard CJ, Lindsay GM, Griffin BA, Caslake MJ, Lorimer AR, Shepherd J. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationship between apolipoprotein B kinetics and plasma lipoproteins. J Lipid Res. 1995;36:158-171.
10. Caslake MJ, Packard CJ, Series JJ, Yip B, Dagen MM, Shepherd J. Plasma triglyceride and low density lipoprotein metabolism. Eur J Clin Invest. 1992;22:96-104.
11. Chang LBF, Hopkins GJ, Barter PJ. Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects. Atherosclerosis. 1985;56:61-70.
12. Tobey TA, Greenfield M, Kraemer F, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism. 1981;30:165-171.
13. Steiner G, Haynes FJ, Yoshino G, Vranic M. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am J Physiol. 1984;246:E187-E192.
14. Topping DL, Mayes PA. Insulin and non-esterified fatty acids: acute regulators of lipogenesis in perfused rat liver. Biochem J. 1982;204:433-439.
15. Sparks CE, Sparks JD, Bolognino M, Salhanic A, Strumph PS, Amatruda JM. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism. 1986;35:1128-1136.
16. Bartlett SM, Gibbons GF. Short- and long-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes: a biphasic effect of insulin. Biochem J. 1988;249:37-43.
17. Salhanick AI, Schwartz SI, Amatruda JM. Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism. 1991;40:275-279.